Home » BIONUTRICS ANNOUNCES AN AGREEMENT TO PURCHASE KIRK PHARMACEUTICALS
BIONUTRICS ANNOUNCES AN AGREEMENT TO PURCHASE KIRK PHARMACEUTICALS
Bionutrics, Inc., a specialty pharmaceutical company engaged in the development and commercialization of generic drugs (ANDAs) and improved formations of previously approved drugs based upon proprietary drug delivery technologies (505(b)(2) applications), announced today that on July 18, 2005, it entered into an agreement to purchase Kirk Pharmaceuticals, LLC and its affiliate, Andapharm, LLC (Kirk). Under the terms of the agreement, Bionutrics will purchase 100% of Kirk for $12 million in a combination of cash and debt.
Yahoo News (http://biz.yahoo.com/prnews/050725/lam044.html?.v=15)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct